Search Results - Lerer, I

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Cystic fibrosis mutations delta F508 and G542X in Jewish patients.

    Cystic fibrosis mutations delta F508 and G542X in Jewish patients. by Lerer, I, Sagi, M, Cutting, G R, Abeliovich, D

    Published 1992
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Homozygosity for Waardenburg syndrome.

    Homozygosity for Waardenburg syndrome. by Zlotogora, J, Lerer, I, Bar-David, S, Ergaz, Z, Abeliovich, D

    Published 1995
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Familial café au lait spots: a variant of neurofibromatosis type 1.

    Familial café au lait spots: a variant of neurofibromatosis type 1. by Abeliovich, D, Gelman-Kohan, Z, Silverstein, S, Lerer, I, Chemke, J, Merin, S, Zlotogora, J

    Published 1995
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Negative expansion of the myotonic dystrophy unstable sequence.

    Negative expansion of the myotonic dystrophy unstable sequence. by Abeliovich, D, Lerer, I, Pashut-Lavon, I, Shmueli, E, Raas-Rothschild, A, Frydman, M

    Published 1993
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.

    The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. by Hubert, A, Peretz, T, Manor, O, Kaduri, L, Wienberg, N, Lerer, I, Sagi, M, Abeliovich, D

    Published 1999
    Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.

    Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. by Abeliovich, D, Lavon, I P, Lerer, I, Cohen, T, Springer, C, Avital, A, Cutting, G R

    Published 1992
    Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction.

    The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. by Lerer, I, Wang, T, Peretz, T, Sagi, M, Kaduri, L, Orr-Urtreger, A, Stadler, J, Gutman, H, Abeliovich, D

    Published 1998
    Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

    The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. by Abeliovich, D, Kaduri, L, Lerer, I, Weinberg, N, Amir, G, Sagi, M, Zlotogora, J, Heching, N, Peretz, T

    Published 1997
    Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians.

    Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. by Cutting, G R, Curristin, S M, Nash, E, Rosenstein, B J, Lerer, I, Abeliovich, D, Hill, A, Graham, C

    Published 1992
    Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.

    Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes. by Friedman, E, Bar-Sade Bruchim, R, Kruglikova, A, Risel, S, Levy-Lahad, E, Halle, D, Bar-On, E, Gershoni-Baruch, R, Dagan, E, Kepten, I, Peretz, T, Lerer, I, Wienberg, N, Shushan, A, Abeliovich, A D

    Published 1998
    Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis.

    Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. by Buiting, K, Dittrich, B, Gross, S, Lich, C, Färber, C, Buchholz, T, Smith, E, Reis, A, Bürger, J, Nöthen, M M, Barth-Witte, U, Janssen, B, Abeliovich, D, Lerer, I, van den Ouweland, A M, Halley, D J, Schrander-Stumpel, C, Smeets, H, Meinecke, P, Malcolm, S, Gardner, A, Lalande, M, Nicholls, R D, Friend, K, Schulze, A, Matthijs, G, Kokkonen, H, Hilbert, P, Van Maldergem, L, Glover, G, Carbonell, P, Willems, P, Gillessen-Kaesbach, G, Horsthemke, B

    Published 1998
    Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: